Galmed Pharmaceuticals Reports First Quarter 2022 Financial Results
/PRNewswire/ —Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic, fibrosis...
Source: prnewswire.com